|
|
 |
MESO SCALE DISCOVERY® launches a new gold standard in streptavidin and high bind avidin-coated plates ensuring unsurpassed performance, consistency and convenience for immunogenicity testing, pharmacokinetic/pharmacodynamic studies, and assay development.
- Improved Plate Performance: Stringent specifications set for consistency, uniformity, and binding capacity
- Guaranteed Lot-to-lot Consistency: Every lot meets consistent release criteria as specified on the full Certificate of Analysis
- Increased Streptavidin Gold Shelf Life: 30-month shelf life assures plate performance in longitudinal studies
- Large Plate Lots: Streptavidin Gold lot sizes of 3000; larger lots available on request
- Assured Availability: Orders shipped within 48 hours of order acceptance
Get high quality and consistent results using our Streptavidin Gold and High Bind Avidin Gold Plates.
- MULTI-ARRAY® 96-well Streptavidin Gold Plates
- Available in 96-well format for the SECTOR PR® and SECTOR® Imager instruments.
- Catalog Numbers: L11SA, L13SA, L15SA
- MULTI-ARRAY 96-well High Bind Avidin Gold Plates
- Available in 96-well format for SECTOR Imager instruments.
- Catalog Numbers: L11AB, L15AB
|
|
The focus of MSD® is to deliver superior and reliable results to our customers. We have implemented rigorous quality control criteria for Streptavidin Gold and High Bind Avidin Gold plates to meet the requirements of the drug safety and toxicology communities. A sample of the quality control specifications are shown below. Please see a Certificate of Analysis for details.
Numerous researchers have utilized the MSD advantage for their assay development needs. Here are a few citations using MSD streptavidin or avidin coated plates for assay development.
 |
Brignone, C., Gutierrez, M., Mefti, F., Brain, E., Jarcau, R., Cvitkovic, F., Bousetta, N., Medioni, J., Gligorov, J., Grygar, C., Marcu, M., Triebel, F. (2010) First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity.J Transl Med. Vol. 8: 71. |
 |
|
Cludts, I., Meager, A., Thorpe, R., Wadhwa, M. (2010) Detection of neutralizing interleukin-17 antibodies in autoimmune polyendocrinopathy syndrome-1 (APS-1) patients using a novel non-cell based electrochemiluminescence assay.Cytokine. Vol. 50(2):129-37. |
|
|
Tatarewicz, S., Miller, J.M., Swanson, S.J., Moxness, M.S. (2010) Rheumatoid factor interference in immunogenicity assays for human monoclonal antibody therapeutics.J Immunol Methods. Vol. 357(1-2):10-6. |
For a complete list of citations using MSD technology for assay development, visit the MSD Bibliography page.
|
|
| |
 |
|
|
MSD takes great pride in the service we provide to our customers. You can search our catalog system to find what you need and request a quote.
To speak with one of our team members or to place an order:
|
|
|
|
Assay development is complex, and we're always here to help. Access to our industry-leading scientific support team is provided complimentary for our customers.
|
|
|
|
|
|
|
Home
Streptavidin and Avidin Gold Plates
